Floatz logo

NEOMYCIN

Pre-Diabetes

University of MinnesotamixturePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

46 Active assets in the Pre-Diabetes cohort.

Asset / SponsorPhaseRating
Metformin
Yu Chen
Phase 4A
Liraglutide
Woman's
Phase 4BBB
Exenatide
RenJi Hospital
Phase 4BBB
Semaglutide
The University of Texas Health Science Center at San Antonio
Phase 4BBB
Semaglutide
Esbjerg Hospital - University Hospital of Southern Denmark
Phase 4BBB

View all 50 →

Same molecule, other indications

NEOMYCIN is also rated in:

Surgical Site InfectionDormant
BBB
Indicative ·
72 / 100
View asset →
Rectum NeoplasmDormant
BB
Indicative ·
65 / 100
View asset →
Surgery--ComplicationsDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →